abstract |
The present invention relates to a capsule compound formulation comprising dutasteride represented by formula I, tadalafil represented by formula II, a fatty acid ester derivative having 8 to 10 carbon atoms, and polysorbate Or polyoxyglyceride-based surfactants, where the two drugs are dissolved: |